Filing Details
- Accession Number:
- 0000899243-21-002307
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-19 09:00:36
- Reporting Period:
- 2021-01-11
- Accepted Time:
- 2021-01-19 09:00:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1183247 | F Gilbert Amelio | C/O Galectin Therapeutics, Inc. 4960 Peachtree Industrial Blvd., Ste 240 Norcross GA 30071 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-11 | 60,000 | $2.17 | 60,614 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold in multiple transactions at prices ranging from $2.16 to $2.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by the Reporting Person at each separate price on each date of purchase.
Billionaire Hedge Funds
